Reuters logo
BRIEF-Labcorp says application of the initiative to covance drug development segment will consist of 2 phases
2017年4月25日 / 晚上8点12分 / 5 个月前

BRIEF-Labcorp says application of the initiative to covance drug development segment will consist of 2 phases

April 25 (Reuters) - Laboratory Corporation Of America Holdings:

* Labcorp says application of the initiative to covance drug development segment will consist of two phases implemented over three years - sec filing

* Labcorp says first phase intended to better align cdd’s resources with near-term outlook

* Labcorp says in connection with the implementation of the first phase, on april 24, 2017, co committed to carry out a reduction in workforce in 2017

* Labcorp says first phase is expected to generate pre-tax savings of about $20 million in 2017 and about $45 million on annualized basis thereafter

* Labcorp says second phase will focus on long-term structural changes designed to create a more efficient business model for cdd Source text - bit.ly/2q3Vohr Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below